Clinical features
| Area of body | How affected |
|---|---|
|
General symptoms Sarcoidosis may cause general symptoms as listed opposite. |
|
|
Lungs Most affected organ, affects more than 90% of patients (In about 50% of cases, the diagnosis is made on a routine Chest X- ray in a person who has no symptoms) |
|
|
Skin The second most commonly affected organ |
Manifestations can be:
|
|
Eye manifestations (Occur in around 15% to 25% of cases) |
Anterior uveitis usually is short- lived, posterior uveitis is generally a more chronic condition. Blindness is rare. |
|
Central Nervous System manifestations Involvement is rare (2%), but the effects can be serious |
|
|
Bone and Joint Involvement (5%) |
|
|
Liver and Spleen (70% liver involvement, 50% liver and spleen involvement) |
|
|
Heart Involvement (3%) Less common, more serious, and more difficult to identify |
|
|
Metabolic |
Hypercalcaemia is found in 10% of established cases. It can lead to the formation of renal stones and other kidney problems. |
* The four lung stages used in the classification of Sarcoidosis (based on chest radiological appearances) are:
1. Hilar lymphadenopathy (enlarged lymph glands at the hila of the lungs) [a person who demonstrates this has a 90% rate of resolution of the disease within 2 to 5 years]
2. Adenopathy (lymph glands affected) & parenchymal (lung tissue) disease co-exist in 30% of cases. [In about 50% of these cases, spontaneous resolutionoccurs within 2 years].
3. Parenchymal disease alone [a person who demonstrates this has a 30% chance of resolution of the disease].
4. Lung fibrosis. This can lead to progressive respiratory failure.
NB. This classification does not relate to the chronological progression of the disease but has international recognition.
From Oxford Textbook of Medicine, 4th edition, Volume2
A restrictive pattern (FEV1/ FVC ratio = normal or increased on lung function studies is normally demonstrated, with reduced lung volumes, but occasionally, an obstructive picture (FEV1/ FVC ratio = less than 75%) can occur. This can occur in smokers or those with endobronchial sarcoid.
For Lung Function Tests in Asthma and COPD:
Amended December 2011
